Point72 Asset Management’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.6M | Buy |
350,973
+224,780
| +178% | +$23.5M | 0.07% | 280 |
|
|
2025
Q1 | $14.7M | Sell |
126,193
-58,945
| -32% | -$6.87M | 0.03% | 441 |
|
|
2024
Q4 | $15.7M | Sell |
185,138
-357,482
| -66% | -$30.2M | 0.03% | 451 |
|
|
2024
Q3 | $48.8M | Buy |
542,620
+63,576
| +13% | +$5.71M | 0.12% | 182 |
|
|
2024
Q2 | $38.6M | Buy |
479,044
+100,180
| +26% | +$8.06M | 0.1% | 249 |
|
|
2024
Q1 | $30.2M | Sell |
378,864
-458,337
| -55% | -$36.6M | 0.07% | 298 |
|
|
2023
Q4 | $66.6M | Buy |
837,201
+305,264
| +57% | +$24.3M | 0.16% | 156 |
|
|
2023
Q3 | $37.2M | Buy |
531,937
+63,934
| +14% | +$4.47M | 0.11% | 221 |
|
|
2023
Q2 | $33.6M | Sell |
468,003
-701,824
| -60% | -$50.4M | 0.1% | 235 |
|
|
2023
Q1 | $72.2M | Buy |
1,169,827
+519,762
| +80% | +$32.1M | 0.22% | 108 |
|
|
2022
Q4 | $50.1M | Buy |
650,065
+32,165
| +5% | +$2.48M | 0.17% | 143 |
|
|
2022
Q3 | $27.6M | Buy |
617,900
+576,125
| +1,379% | +$25.7M | 0.11% | 237 |
|
|
2022
Q2 | $1.6M | Buy |
+41,775
| New | +$1.6M | 0.01% | 784 |
|
|
2021
Q2 | – | Sell |
-42,300
| Closed | -$2.4M | – | 909 |
|
|
2021
Q1 | $2.4M | Sell |
42,300
-35,200
| -45% | -$1.99M | 0.01% | 659 |
|
|
2020
Q4 | $6.31M | Sell |
77,500
-13,157
| -15% | -$1.07M | 0.03% | 515 |
|
|
2020
Q3 | $6.46M | Sell |
90,657
-168,740
| -65% | -$12M | 0.03% | 470 |
|
|
2020
Q2 | $21.3M | Sell |
259,397
-424,857
| -62% | -$35M | 0.14% | 202 |
|
|
2020
Q1 | $40.3M | Buy |
+684,254
| New | +$40.3M | 0.33% | 75 |
|
|
2019
Q4 | – | Sell |
-160,000
| Closed | -$3.24M | – | 915 |
|
|
2019
Q3 | $3.24M | Buy |
+160,000
| New | +$3.24M | 0.02% | 485 |
|
|
2019
Q1 | – | Sell |
-250,000
| Closed | -$705K | – | 914 |
|
|
2018
Q4 | $705K | Buy |
+250,000
| New | +$705K | ﹤0.01% | 749 |
|